Bristol’s Boerner To Succeed CEO Caforio With Launch Execution In The Spotlight
Executive Summary
Giovanni Caforio will step down as CEO of Bristol Myer Squibb effective 1 November, with chief commercialization officer Boerner primed to succeed him.